Menu
13 Apr 2026

Holland & Knight adds Partner Shira A. Selengut to Executive Compensation and Benefits team in New York

"Shira A. Selengut joins Holland & Knight in New York as a partner on the Executive Compensation and Benefits team, focusing on ERISA, employee benefits and executive compensation."

Shira A. Selengut has joined Holland & Knight’s New York office as a partner on the firm’s Executive Compensation and Benefits Team. She was previously a partner with Katten Muchin Rosenmann LLP.

Ms. Selengut’s practice focuses primarily on the Employee Retirement Income Security Act of 1974 (ERISA), employee benefits and executive compensation. She regularly advises financial institutions, private equity sponsors and investment funds on ERISA plan asset, fiduciary responsibility and prohibited transaction rules. Her experience also includes advising public and private companies and private equity firms on the design and implementation of annual and long-term incentive plans, equity and equity-based compensation arrangements, employment and separation agreements, and severance and retention programs. She also counsels clients on the tax implications of compensation structures and on the application of securities laws, labor and employment laws, and other laws governing hiring, workforce reduction and restrictive covenants.

Ms. Selengut joins Holland & Knight as a partner, having been a partner at Katten Muchin Rosenmann LLP. She earned her J.D. from Fordham University School of Law and her B.S. from Rutgers Business School.
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.